All Curated Mutation Sites in JEV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in JEV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
C
  
E
  
NS1
  
NS2A
  
NS2B
  
NS3
  
NS4B
  
NS5
  
prM
  

Keyword: prM
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 26261169 K218R
prM
prM
JEV Infection
G
R
S
L
View
2 31381617 M44L
prM
prM
Cell line
G
View
3 31381617 S90T
prM
prM
Cell line
G
View
4 31381617 N148T
prM
prM
Cell line
G
View
5 31381617 N149T
prM
prM
Cell line
G
View
6 31381617 T57A
prM
prM
Cell line
G
View
7 31381617 M58V
prM
prM
Cell line
G
View
8 31381617 A58V
prM
prM
Cell line
G
View
9 31381617 V140T
prM
prM
Cell line
G
View
10 31381617 V140A
prM
prM
Cell line
G
View
11 31381617 N149S
prM
prM
Cell line
G
View
12 18524814 N15A
prM
prM
Cell line
R
View
13 18524814 T17A
prM
prM
Cell line
R
View
14 18524814 N15Q
prM
prM
Cell line
R
View
15 37819933 T17A
prM
prM
Cell line
R
View
16 37819933 N15A
prM
prM
Cell line
R
View
17 39775684 G21D
prM
prM
Cell line
R
View
18 15956595 H99A
prM
prM
Cell line
R
View
19 15956595 G100A
prM
prM
Cell line
R
View
20 15956595 E101A
prM
prM
Cell line
R
View
21 15956595 S102A
prM
prM
Cell line
R
View
22 15956595 S103A
prM
prM
Cell line
R
View
23 24709585 C677T
prM
prM
Cell line
JEV Infection
R
View
24 24709585 C909T
prM
prM
Cell line
JEV Infection
R
View
25 24709585 L145F
prM
prM
Cell line
JEV Infection
R
View
Contents
Description

The table shows all curated mutation sites of JEV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.